[Evidence and guidelines for influenza and pneumococcal vaccines for the elderly]
Jan Gerstoft1, Marie Helleberg
1Klinik for Infektionsmedicin og Reumatologi, Epidemiklinikken 5112, Rigshospitalet, Blegdamsvej 9, 2100 København Ø. jan.gerstoft@regionh.dk
Abstract:
Influenza and pneumococcal disease are major causes of morbidity and mortality in the elderly. In most European countries dual vaccination of persons aged > 65 years is recommended, but the evidence supporting these recommendations is limited. Inadequate immune response in elderly hampers efficacy. Immunogenicity of the influenza vaccine may be improved by adding an adjuvant. Pneumococcal vaccination of children provides herd immunity, but may also result in expansion of non-vaccine strains. Better vaccines with documentation of efficacy in the elderly are needed for both diseases.
More Related Videos
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
